83 related articles for article (PubMed ID: 12897064)
21. Pleiotropic regulations of neutrophil receptors response to sepsis.
Zhang H; Sun B
Inflamm Res; 2017 Mar; 66(3):197-207. PubMed ID: 27695874
[TBL] [Abstract][Full Text] [Related]
22. A novel "complement-metabolism-inflammasome axis" as a key regulator of immune cell effector function.
Arbore G; Kemper C
Eur J Immunol; 2016 Jul; 46(7):1563-73. PubMed ID: 27184294
[TBL] [Abstract][Full Text] [Related]
23. A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement System.
Jusko M; Potempa J; Mizgalska D; Bielecka E; Ksiazek M; Riesbeck K; Garred P; Eick S; Blom AM
J Immunol; 2015 Sep; 195(5):2231-40. PubMed ID: 26209620
[TBL] [Abstract][Full Text] [Related]
24. CD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil Dysfunction.
Schmidt T; Brodesser A; Schnitzler N; Grüger T; Brandenburg K; Zinserling J; Zündorf J
PLoS One; 2015; 10(7):e0132703. PubMed ID: 26176669
[TBL] [Abstract][Full Text] [Related]
25. Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis.
Ning C; Li YY; Wang Y; Han GC; Wang RX; Xiao H; Li XY; Hou CM; Ma YF; Sheng DS; Shen BF; Feng JN; Guo RF; Li Y; Chen GJ
Mucosal Immunol; 2015 Nov; 8(6):1275-84. PubMed ID: 25736459
[TBL] [Abstract][Full Text] [Related]
26. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis.
Xu R; Lin F; Bao C; Huang H; Ji C; Wang S; Jin L; Sun L; Li K; Zhang Z; Wang FS
Cell Mol Immunol; 2016 Jan; 13(1):103-9. PubMed ID: 25726869
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcal proteases aid in evasion of the human complement system.
Jusko M; Potempa J; Kantyka T; Bielecka E; Miller HK; Kalinska M; Dubin G; Garred P; Shaw LN; Blom AM
J Innate Immun; 2014; 6(1):31-46. PubMed ID: 23838186
[TBL] [Abstract][Full Text] [Related]
28. New insights for C5a and C5a receptors in sepsis.
Yan C; Gao H
Front Immunol; 2012; 3():368. PubMed ID: 23233853
[TBL] [Abstract][Full Text] [Related]
29. Protease-dependent mechanisms of complement evasion by bacterial pathogens.
Potempa M; Potempa J
Biol Chem; 2012 Sep; 393(9):873-88. PubMed ID: 22944688
[TBL] [Abstract][Full Text] [Related]
30. Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice.
Gonzalez JM; Franzke CW; Yang F; Romero R; Girardi G
Am J Pathol; 2011 Aug; 179(2):838-49. PubMed ID: 21801872
[TBL] [Abstract][Full Text] [Related]
31. Complement inhibition alleviates paraquat-induced acute lung injury.
Sun S; Wang H; Zhao G; An Y; Guo Y; Du L; Song H; Qiao F; Yu H; Wu X; Atkinson C; Jiang S; Tomlinson S; Zhou Y
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):834-42. PubMed ID: 21421909
[TBL] [Abstract][Full Text] [Related]
32. Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis.
Dahlke K; Wrann CD; Sommerfeld O; Sossdorf M; Recknagel P; Sachse S; Winter SW; Klos A; Stahl GL; Ma YX; Claus RA; Reinhart K; Bauer M; Riedemann NC
J Immunol; 2011 Mar; 186(5):3066-75. PubMed ID: 21263075
[TBL] [Abstract][Full Text] [Related]
33. Role of C5 activation products in sepsis.
Ward PA
ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.
Sun L; Guo RF; Gao H; Sarma JV; Zetoune FS; Ward PA
FASEB J; 2009 Nov; 23(11):3808-18. PubMed ID: 19620403
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490.
Dimitrova P; Gyurkovska V; Shalova I; Saso L; Ivanovska N
J Inflamm (Lond); 2009 May; 6():13. PubMed ID: 19416544
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the antitumor immune response by complement.
Markiewski MM; DeAngelis RA; Benencia F; Ricklin-Lichtsteiner SK; Koutoulaki A; Gerard C; Coukos G; Lambris JD
Nat Immunol; 2008 Nov; 9(11):1225-35. PubMed ID: 18820683
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.
Arumugam TV; Woodruff TM; Lathia JD; Selvaraj PK; Mattson MP; Taylor SM
Neuroscience; 2009 Feb; 158(3):1074-89. PubMed ID: 18691639
[TBL] [Abstract][Full Text] [Related]
38. New insights into cellular mechanisms during sepsis.
Hoesel LM; Gao H; Ward PA
Immunol Res; 2006; 34(2):133-41. PubMed ID: 16760573
[TBL] [Abstract][Full Text] [Related]
39. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
40. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.
Soto E; Richani K; Romero R; Espinoza J; Chaiworapongsa T; Nien JK; Edwin S; Kim YM; Hong JS; Goncalves L; Mazor M
J Matern Fetal Neonatal Med; 2005 Apr; 17(4):247-52. PubMed ID: 16147833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
